CHOICE: CHOosing treatment together In Cancer at the End of life<br> - CHOICE: CHOosing treatment together In Cancer at the End of life

Academisch Medisch Centrum0 个研究点目标入组 192 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•1. diagnosed with metastasized or locally irresectable cancer
•2. not eligible for treatment with curative intent
•3. median life expectancy of <1 year without systemic treatment, and a median survival benefit of systemic treatment of <6 months. This includes, but is not limited to:
•a. patients with metastases or locally irresectable tumors of the pancreas, esophageus, stomach, liver, gall bladder, and bladder, and patients with metastatic sarcoma or melanoma
•b. patients with advanced cancer, irrespective of tumour type, who have experienced progression under first line palliative systemic treatment.
•4. scheduled for a consultation with a participating medical oncologist in which decisions about the start, (dis)continuation or adjustment of palliative systemic treatment will be made. This includes consultations in which:
•a. a decision to start, forego or postpone a (new line of) systemic treatment will be made
•b. current systemic treatment is evaluated after a fixed number of cycles and a decision to (dis)continue and/or adjust systemic treatment will be made;Oncologists
•Eligible are all medical oncologists (in training) treating the eligible patient population with an appointment of at least 1 year after the start of the trial.

•A potential subject who meets any of the following criteria will be excluded from participation in this study:
•1. insufficient mastery of Dutch, i.e., inability to understand the 'Gesprekswijzer' as well as the questionnaires as judged by either the physician or the researcher
•2. cognitive disabilities or a psychiatric disorder that hinder understanding of the 'Gesprekswijzer' as well as the questionnaires as judged by either the physician or the researcher
•3. not enough time (<2 days) to make sure the Gesprekswijzer is received before the consultation in which decisions are made
•4. a primary brain tumor or brain metastasizes which significantly affect cognitive functioning;Oncologists
•Excluded will be oncologists involved in the design of the content of the interventions.

发起方